Related Experiment Videos
[Tactics of hypolipidemic therapy after myocardial revascularization]
J Chlumský1, P Dostálová, D Holá
1Interní klinika FN Motol, Praha.
Insights
Hypolipidaemic treatment for ischemic heart disease (IHD) patients post-revascularization is often inadequate. Starting statin therapy before hospital discharge significantly improves lipid profiles and is well-tolerated.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Inadequate hypolipidaemic treatment is prevalent in Czech Republic patients with ischemic heart disease (IHD).
- Patients undergoing revascularization often lack appropriate lipid-lowering medication upon discharge, despite altered lipid profiles post-surgery.
Purpose of the Study:
- To assess the initiation of hypolipidaemic treatment during hospitalization or follow-up for patients post-revascularization.
- To evaluate the effectiveness and tolerability of fluvastatin in improving lipid spectrum.
Main Methods:
- Retrospective analysis of 100 patients discharged without hypolipidaemic treatment and 40 patients treated with fluvastatin pre-surgery.
- Questionnaire-based assessment of lipid level monitoring and treatment initiation in the non-pharmacological group.
Main Results:
- In the group without intervention, only 36% had lipid levels checked, and 14% initiated hypolipidaemic treatment.
- Patients receiving fluvastatin showed 100% adherence and significant improvement in lipid spectrum.
- Fluvastatin treatment was well-tolerated.
Conclusions:
- Hypolipidaemic treatment post-revascularization should be initiated before hospital discharge.
- Considering preoperative lipid levels is crucial for effective post-operative management.
- Early and consistent statin therapy improves outcomes in IHD patients.
Abstract:
Previous investigations revealed that hypolipidaemic treatment of patients with IHD in the Czech Republic is inadequate. Patients after revascularization operations are discharged from cardiosurgical departments without suitable medication and moreover the values of the lipid spectrum are affected by the surgical intervention. The objective of the investigation was to evaluate the indication of hypolipidaemic treatment during hospitalization or later during check-up examinations by attending physicians. The authors evaluated retrospectively 100 patients after revascularization operations of the heart discharged without hypolipidaemic treatment and 40 patients treated with fluvastatin because of the lipid values before surgery. Using questionnaires it was revealed that in the group without pharmacological intervention in 36% patients the lipid levels were checked and hypolipidaemic treatment was started in 14% of the patients. In the patients with pharmacological treatment 100% adherence to treatment and improvement of the lipid spectrum was found similarly as in comparable trials. Fluvastatin treatment was well tolerated. In the authors view hypolipidaemic treatment after revascularization should be started before discharge from hospital with regard to preoperative results of the lipid spectrum.